0
Upcoming Allied Market Research
2023
Stent Grafts Market

Stent Grafts Market

by Product (Endovascular, Synthetic Stent Graft System), by Application (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA)) and by Type (Aorta-uni-iliac (AUI) Stent Grafts, Bifurcated Stent Grafts): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A02351
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Stent Grafts Market

Request Now !

Stent grafts are tubular-shaped devices with metallic frame used during endovascular aneurysm repair (EVAR) procedures. It is a minimally invasive procedure, during which the grafts are implanted in the patients to support the damaged area from rupturing.

The growth of the global stent grafts market is driven by factors such as rise in hypertension, growth in geriatric population, and increase in awareness about aneurysm. In addition, rise in demand for minimally invasive procedure, technological advancements, and changes in lifestyle (consumption of junk food, tobacco, and alcohol) are expected to boost the market growth.

However, high cost of treatment, complications associated with stent grafts, and lack of awareness in developing region restrain the market growth. Favorable reimbursements and development in healthcare infrastructure in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous growth opportunities for the market growth during the forecast period.

The report analyzes the global stent grafts market based on product, application, type, and geography. In terms of product, the market is divided into endovascular and synthetic stent graft system. Applications covered in the study include abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of type, the market is categorized into aorta-uni-iliac (AUI) and bifurcated stent grafts.

Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Thailand, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, and rest of LAMEA).

Key players operating in the market include Cook Medical Inc., Endologix, Inc., W. L. Gore & Associates, Inc., Medtronic plc, C. R. Bard, Inc., Lombard Medical, Inc., Terumo Corporation, MicroPort Scientific Corporation, Merit Medical, B. Braun Melsungen AG, and Lifetech Scientific (Shenzhen) Co. Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
  • The report offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Exhaustive analysis by product, application, and type helps to understand the products used and the variants that are expected to gain prominence in the future.

Stent Grafts Market Report Highlights

Aspects Details
By Product
  • Endovascular
  • Synthetic Stent Graft System
By Application
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
By Type
  • Aorta-uni-iliac (AUI) Stent Grafts
  • Bifurcated Stent Grafts
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Medtronic plc., Terumo Corporation, Lombard Medical, Inc., MicroPort Scientific Corporation, Endologix, Inc., Merit Medical, Lifetech Scientific (Shenzhen) Co. Ltd., W. L. Gore and Associates, Inc., C. R. Bard, Inc., Cook Medical Inc., B. Braun Melsungen AG
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: STENT GRAFTS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Endovascular

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Synthetic Stent Graft System

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: STENT GRAFTS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Abdominal Aortic Aneurysm (AAA)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Thoracic Aortic Aneurysm (TAA)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: STENT GRAFTS MARKET, BY TYPE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Type

    • 6.2. Aorta-uni-iliac (AUI) Stent Grafts

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Bifurcated Stent Grafts

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: STENT GRAFTS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Type

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Stent Grafts Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Type
      • 7.2.7. Canada Stent Grafts Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Type
      • 7.2.8. Mexico Stent Grafts Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Type
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Type

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Stent Grafts Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Type
      • 7.3.7. Germany Stent Grafts Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Type
      • 7.3.8. Italy Stent Grafts Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Type
      • 7.3.9. Spain Stent Grafts Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Type
      • 7.3.10. UK Stent Grafts Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Type
      • 7.3.11. Russia Stent Grafts Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Type
      • 7.3.12. Rest Of Europe Stent Grafts Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Type
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Type

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Stent Grafts Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Type
      • 7.4.7. Japan Stent Grafts Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Type
      • 7.4.8. India Stent Grafts Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Type
      • 7.4.9. South Korea Stent Grafts Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Type
      • 7.4.10. Australia Stent Grafts Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Type
      • 7.4.11. Thailand Stent Grafts Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Type
      • 7.4.12. Malaysia Stent Grafts Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Type
      • 7.4.13. Indonesia Stent Grafts Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Type
      • 7.4.14. Rest of Asia Pacific Stent Grafts Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Type
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Type

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Stent Grafts Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Type
      • 7.5.7. South Africa Stent Grafts Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Type
      • 7.5.8. Saudi Arabia Stent Grafts Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Type
      • 7.5.9. UAE Stent Grafts Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Type
      • 7.5.10. Argentina Stent Grafts Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Type
      • 7.5.11. Rest of LAMEA Stent Grafts Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Type
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Cook Medical Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Endologix, Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. W. L. Gore And Associates, Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Medtronic Plc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. C. R. Bard, Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Lombard Medical, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Terumo Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. MicroPort Scientific Corporation

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Merit Medical

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. B. Braun Melsungen AG

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Lifetech Scientific (Shenzhen) Co. Ltd.

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL STENT GRAFTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL STENT GRAFTS MARKET FOR ENDOVASCULAR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL STENT GRAFTS MARKET FOR SYNTHETIC STENT GRAFT SYSTEM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL STENT GRAFTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL STENT GRAFTS MARKET FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL STENT GRAFTS MARKET FOR THORACIC AORTIC ANEURYSM (TAA), BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL STENT GRAFTS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL STENT GRAFTS MARKET FOR AORTA-UNI-ILIAC (AUI) STENT GRAFTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL STENT GRAFTS MARKET FOR BIFURCATED STENT GRAFTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL STENT GRAFTS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA STENT GRAFTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. U.S. STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. U.S. STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. CANADA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. CANADA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. CANADA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE STENT GRAFTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. FRANCE STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. FRANCE STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. ITALY STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. ITALY STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. ITALY STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. SPAIN STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. SPAIN STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. SPAIN STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. UK STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. UK STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. UK STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. RUSSIA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. RUSSIA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. RUSSIA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC STENT GRAFTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. CHINA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. CHINA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. CHINA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. INDIA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. INDIA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. INDIA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH KOREA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH KOREA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. THAILAND STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. THAILAND STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. THAILAND STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. MALAYSIA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. MALAYSIA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. MALAYSIA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. INDONESIA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. INDONESIA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. INDONESIA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. REST OF ASIA PACIFIC STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. LAMEA STENT GRAFTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 81. LAMEA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. LAMEA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. BRAZIL STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. BRAZIL STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. BRAZIL STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH AFRICA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH AFRICA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. SAUDI ARABIA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. SAUDI ARABIA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. SAUDI ARABIA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. UAE STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. UAE STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. UAE STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. ARGENTINA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. ARGENTINA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. ARGENTINA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. REST OF LAMEA STENT GRAFTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. REST OF LAMEA STENT GRAFTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. REST OF LAMEA STENT GRAFTS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 102. COOK MEDICAL INC.: KEY EXECUTIVES
  • TABLE 103. COOK MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 104. COOK MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 105. COOK MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 106. COOK MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. ENDOLOGIX, INC.: KEY EXECUTIVES
  • TABLE 108. ENDOLOGIX, INC.: COMPANY SNAPSHOT
  • TABLE 109. ENDOLOGIX, INC.: OPERATING SEGMENTS
  • TABLE 110. ENDOLOGIX, INC.: PRODUCT PORTFOLIO
  • TABLE 111. ENDOLOGIX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. W. L. GORE AND ASSOCIATES, INC.: KEY EXECUTIVES
  • TABLE 113. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
  • TABLE 114. W. L. GORE AND ASSOCIATES, INC.: OPERATING SEGMENTS
  • TABLE 115. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
  • TABLE 116. W. L. GORE AND ASSOCIATES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 118. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 119. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 120. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 121. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. C. R. BARD, INC.: KEY EXECUTIVES
  • TABLE 123. C. R. BARD, INC.: COMPANY SNAPSHOT
  • TABLE 124. C. R. BARD, INC.: OPERATING SEGMENTS
  • TABLE 125. C. R. BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 126. C. R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. LOMBARD MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 128. LOMBARD MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 129. LOMBARD MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 130. LOMBARD MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 131. LOMBARD MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 133. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 134. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 135. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 138. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 139. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 140. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 141. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. MERIT MEDICAL: KEY EXECUTIVES
  • TABLE 143. MERIT MEDICAL: COMPANY SNAPSHOT
  • TABLE 144. MERIT MEDICAL: OPERATING SEGMENTS
  • TABLE 145. MERIT MEDICAL: PRODUCT PORTFOLIO
  • TABLE 146. MERIT MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 148. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 149. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 150. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 151. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: KEY EXECUTIVES
  • TABLE 153. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: COMPANY SNAPSHOT
  • TABLE 154. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: OPERATING SEGMENTS
  • TABLE 155. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 156. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL STENT GRAFTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL STENT GRAFTS MARKET
  • FIGURE 3. SEGMENTATION STENT GRAFTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN STENT GRAFTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALSTENT GRAFTS MARKET
  • FIGURE 11. STENT GRAFTS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. STENT GRAFTS MARKET FOR ENDOVASCULAR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. STENT GRAFTS MARKET FOR SYNTHETIC STENT GRAFT SYSTEM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. STENT GRAFTS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. STENT GRAFTS MARKET FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. STENT GRAFTS MARKET FOR THORACIC AORTIC ANEURYSM (TAA), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. STENT GRAFTS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 18. STENT GRAFTS MARKET FOR AORTA-UNI-ILIAC (AUI) STENT GRAFTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. STENT GRAFTS MARKET FOR BIFURCATED STENT GRAFTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: STENT GRAFTS MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. COOK MEDICAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. COOK MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. COOK MEDICAL INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. ENDOLOGIX, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. ENDOLOGIX, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. ENDOLOGIX, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. W. L. GORE AND ASSOCIATES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. MEDTRONIC PLC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. C. R. BARD, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. C. R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. C. R. BARD, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. LOMBARD MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. LOMBARD MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. LOMBARD MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. MERIT MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. MERIT MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. MERIT MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Stent Grafts Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers